Neutrophil membrane-coated nanoparticles for targeted delivery of toll-like receptor 4 siRNA ameliorate LPS-induced acute lung injury

被引：1

作者：

Cao, Liang ^{[1
]}

Du, Min ^{[2
]}

Cai, Mengmeng ^{[2
]}

Feng, Yan ^{[2
]}

Miao, Juanjuan ^{[2
]}

Sun, Jiafeng ^{[2
]}

Song, Jie ^{[2
]}

Du, Boxiang ^{[2
]}

机构：

[1] Nantong Univ, Affiliated Hosp 2, Dept ICU, Nantong 226014, Jiangsu, Peoples R China

[2] Nantong Univ, Affiliated Hosp 2, Dept Anesthesiol, Nantong 226014, Jiangsu, Peoples R China

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2025年 / 668卷

关键词：

Acute lung injury; Neutrophil membrane-coated nanoparticles; Drug delivery; si-TLR4; Inflammation; INFLAMMATORY MACROPHAGES; CELL; TLR4/NF-KAPPA-B; AQP5; SIZE; DEXMEDETOMIDINE; EXPRESSION; SHAPE; RATS;

D O I：

10.1016/j.ijpharm.2024.124960

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pulmonary delivery of small interfering RNAs (siRNAs) is an effective treatment for acute lung injury (ALI), which can modulate the expression of pro-inflammatory cytokines and alleviate the symptoms of ALI. However, the rapid degradation of siRNA in vivo and its limited ability to target and validate cells are important challenges it faces in clinical practice. In this work, we developed neutrophil membrane-coated Poly (lactic-co-glycolic acid) nanoparticles loaded with TLR4 siRNA (si-TLR4) (Neutrophil-NP-TLR4), which can target both inflammatory and macrophage cells to alleviate the pulmonary inflammation in lipopolysaccharide (LPS)-induced ALI mice. These Neutrophil-NP-TLR4 effectively reduce the TNF-alpha and IL-1 beta expressions both in vitro and in vivo. Meanwhile, they also reduced the expression of TLR4, and its downstream genes including TNF receptor-associated factor 6 (TRAF6), X-linked inhibitor of apoptosis protein (XIAP), and Nuclear Factor kappa-B (NF-kappa B), but elevated the levels of Aquaporin 1 (AQP1) and Aquaporin 5 (AQP5). Moreover, the Neutrophil-NP-TLR4 precisely targets the inflammatory site to attenuate the lung injury without causing toxicity to normal tissue. This system provides a promising approach to effective delivery of siRNA to precisely treat the ALI.

引用

页数：13

共 64 条

[1] Bagalkot V., Badgeley M.A., Kampfrath T., Et al., Deiuliis JA, Rajagopalan S, Maiseyeu A. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals, J. Control. Release, 217, pp. 243-255, (2015)
[2] Campanero M.R., del Pozo M.A., Arroyo A.G., Et al., ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway, J. Cell Biol., 123, pp. 1007-1016, (1993)
[3] Cao X., Hu Y., Luo S., Et al., Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma, Acta Pharm. Sin. B, 9, pp. 575-589, (2019)
[4] Cao C., Yin C., Shou S., Et al., Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators, Shock (augusta, Ga.), 50, pp. 595-605, (2018)
[5] Ceylan S., Bahadori F., Akbas F., Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment, Pharm. Dev. Technol., 25, pp. 855-864, (2020)
[6] Chen M., Chen M., He J., Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA, Artif. Cells Nanomed. Biotechnol., 47, pp. 1635-1641, (2019)
[7] Chen S.N., Tan Y., Xiao X.C., Et al., Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis, Acta Pharmacol. Sin., (2021)
[8] Chi G., Zhong W., Liu Y., Et al., pp. 33-41, (2016)
[9] Chithrani B.D., Ghazani A.A., Chan W.C., Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett., 6, pp. 662-668, (2006)
[10] Deng G., He H., Chen Z., Et al., Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway, Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 96, pp. 148-152, (2017)

← 1 2 3 4 5 6 7 →